SG/CALL/IPSEN/120/0.05/21.06.24 | Market Closed - Euronext Paris 17:30:00 29/05/2024 BST | ||
| 0.145 EUR | 0.00% |
|
| Current month | +11.54% | ||
| 1 month | +31.82% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 29/05/24 | 0.145 | 0.00% |
| 28/05/24 | 0.145 | -17.14% |
| 27/05/24 | 0.175 | -27.08% |
| 24/05/24 | 0.24 | -14.29% |
| 23/05/24 | 0.28 | +16.67% |
Real-time Euronext Paris
Last update May 29, 2024 at 05:30 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
Société Générale
|
| 9R23S | |
| ISIN | DE000SW72B20 |
| Date issued | 21/03/2024 |
| Strike | 120 € |
| Maturity | 21/06/2024 (23 Days) |
| Parity | 20 : 1 |
| Emission price | 0.1 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.3 € |
|---|---|
| Lowest since issue | 0.065 € |
| Spread | 0.03 € |
| Spread % | 18.75% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
120
EUR
Average target price
126.4
EUR
Spread / Average Target
+5.33%
- Stock Market
- Warrants
- 9R23S Warrant
